Ategra Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,987
| Closed | -$1.27M | – | 23 |
|
|
2024
Q1 | $1.27M | Hold |
6,987
| – | – | 0.57% | 38 |
|
|
2023
Q4 | $1.08M | Buy |
6,987
+349
| +5% | +$54.1K | 0.48% | 41 |
|
|
2023
Q3 | $989K | Buy |
6,638
+3,018
| +83% | +$450K | 0.54% | 43 |
|
|
2023
Q2 | $488K | Buy |
3,620
+594
| +20% | +$80K | 0.26% | 58 |
|
|
2023
Q1 | $482K | Hold |
3,026
| – | – | 0.26% | 63 |
|
|
2022
Q4 | $489K | Hold |
3,026
| – | – | 0.25% | 61 |
|
|
2022
Q3 | $406K | Hold |
3,026
| – | – | 0.21% | 67 |
|
|
2022
Q2 | $463K | Hold |
3,026
| – | – | 0.24% | 64 |
|
|
2022
Q1 | $491K | Hold |
3,026
| – | – | 0.22% | 69 |
|
|
2021
Q4 | $410K | Hold |
3,026
| – | – | 0.18% | 80 |
|
|
2021
Q3 | $326K | Sell |
3,026
-98
| -3% | -$10.6K | 0.16% | 85 |
|
|
2021
Q2 | $352K | Buy |
3,124
+25
| +0.8% | +$2.82K | 0.17% | 82 |
|
|
2021
Q1 | $335K | Buy |
3,099
+80
| +3% | +$8.66K | 0.19% | 82 |
|
|
2020
Q4 | $323K | Buy |
3,019
+52
| +2% | +$5.57K | 0.23% | 75 |
|
|
2020
Q3 | $260K | Sell |
2,967
-868
| -23% | -$76K | 0.23% | 71 |
|
|
2020
Q2 | $377K | Buy |
3,835
+548
| +17% | +$53.8K | 0.36% | 58 |
|
|
2020
Q1 | $250K | Buy |
3,287
+302
| +10% | +$23K | 0.29% | 61 |
|
|
2019
Q4 | $264K | Buy |
2,985
+56
| +2% | +$4.96K | 0.22% | 74 |
|
|
2019
Q3 | $222K | Sell |
2,929
-761
| -21% | -$57.6K | 0.2% | 87 |
|
|
2019
Q2 | $268K | Sell |
3,690
-100
| -3% | -$7.27K | 0.25% | 81 |
|
|
2019
Q1 | $305K | Buy |
+3,790
| New | +$305K | 0.3% | 72 |
|